Replies to post #2937 on Idenix Pharmaceuticals (IDIX)

[DewDiligence]

Bullish insider transaction reported today:

#msg-43558137

[DewDiligence]

IDIX Insider Shareholdings

[Updated for David Standring’s option exercise on 11/11/09.
Options listed below include both vested and non-vested holdings.]

 
 Executive Officers  
 JP Sommadossi, CEO       2,220K shares  1,806 options 
 Ron Renaud, CFO             15K shares   455K options 
 Doug Mayers, CMO            30K shares   260K options 
 David Standring, EVP Bio    68K shares   100K options 
 John Weidenbruch, Gen Cnsl  15K shares   275K options 
 Paul Fanning, SVP HR         1K shares    70K options 
 -- 
 Six executive officers   2,349K shares 2,966K options

 
 Independent directors  
 Charles Cramb                7K shares   140K options 
 Wayne Hockmeyer             42K shares   100K options 
 Thomas Hodgson              42K shares   100K options 
 Denise Pollard-Knight         0 shares    80K options 
 Pamela Thomas-Graham          0 shares   115K options 
 -- 
 Five independent dirctrs    91K shares   535K options

 
 All officers/directors   2,440K shares 3,501K options